Join the conversation
Drop your email in the form below, and you will receive our medtech articles as soon as they're published.
I had the privilege of interviewing the Value Analysis Whisperer himself, Mark Copeland, who cracked open the black box of Value Analysis Committees and shared the secrets that MedTech companies...
You’ve probably heard of Proteus.
At one time it was the darling of digital health. But within a single year, Proteus went from a $1.5B valuation to a fire sale at $15m.
...
Quick 510(k) = Quick exit
Right?
Not quite.
Here's some interesting data:
SVB: 2019 Trends in Healthcare Investments and Exits
Ok, the data is a bit dated. But the push...
Written by Eric Sugalski
Consider this analogy.. You are driving across the US, planning for a week to travel from coast to coast. With elevated gas prices you want...
Hey – Eric here.
Here are 4 steps on how to clearly define the clinical outcome that compels adoption of your new medical device.
Today’s issue of Medtech Mindset takes about 3 minutes...
Consider a medical device startup, facing a critical market decision:
Should the company go big, aiming for the $1B market out of the gate? Or should the company go small, proving value with an...
Written by Eric Sugalski and Ulrich Herken
True story.
A medical device manufacturer developed an at-home wearable defibrillator for populations at high risk of sudden cardiac death. This device...
Clinical use is a significant milestone for most medical device companies. Investors often see this milestone as a significant de-risking activity – one that can come with valuation...
Written by Eric Sugalski and Ulrich Herken
“You need to show clinical evidence that your medical device provides a benefit.”
It's a common request that early medical...